These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 19159907

  • 1. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
    Patiño-García A, Zalacaín M, Marrodán L, San-Julián M, Sierrasesúmaga L.
    J Pediatr; 2009 May; 154(5):688-93. PubMed ID: 19159907
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of methotrexate resistance in osteosarcoma.
    Guo W, Healey JH, Meyers PA, Ladanyi M, Huvos AG, Bertino JR, Gorlick R.
    Clin Cancer Res; 1999 Mar; 5(3):621-7. PubMed ID: 10100715
    [Abstract] [Full Text] [Related]

  • 3. Association of SNPs in genes involved in folate metabolism with the risk of congenital heart disease.
    Wang B, Liu M, Yan W, Mao J, Jiang D, Li H, Chen Y.
    J Matern Fetal Neonatal Med; 2013 Dec; 26(18):1768-77. PubMed ID: 23701284
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue.
    Chiusolo P, Giammarco S, Bellesi S, Metafuni E, Piccirillo N, De Ritis D, Marietti S, Federica S, Laurenti L, Fianchi L, Hohaus S, Giuseppe L, Sica S.
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):691-6. PubMed ID: 21984221
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Kumagai K, Hiyama K, Oyama T, Maeda H, Kohno N.
    Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
    [Abstract] [Full Text] [Related]

  • 8. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
    van Kooten Niekerk PB, Schmiegelow K, Schroeder H.
    Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
    Wessels JA, de Vries-Bouwstra JK, Heijmans BT, Slagboom PE, Goekoop-Ruiterman YP, Allaart CF, Kerstens PJ, van Zeben D, Breedveld FC, Dijkmans BA, Huizinga TW, Guchelaar HJ.
    Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
    [Abstract] [Full Text] [Related]

  • 10. Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.
    Jabeen S, Holmboe L, Alnæs GI, Andersen AM, Hall KS, Kristensen VN.
    Pharmacogenomics J; 2015 Oct; 15(5):385-90. PubMed ID: 25778468
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.
    Goričar K, Kovač V, Jazbec J, Zakotnik B, Lamovec J, Dolžan V.
    Pharmacogenet Genomics; 2014 Oct; 24(10):514-21. PubMed ID: 25098908
    [Abstract] [Full Text] [Related]

  • 13. Association between SNPs in genes involved in folate metabolism and preterm birth risk.
    Wang BJ, Liu MJ, Wang Y, Dai JR, Tao JY, Wang SN, Zhong N, Chen Y.
    Genet Mol Res; 2015 Feb 02; 14(1):850-9. PubMed ID: 25730024
    [Abstract] [Full Text] [Related]

  • 14. Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
    Windsor RE, Strauss SJ, Kallis C, Wood NE, Whelan JS.
    Cancer; 2012 Apr 01; 118(7):1856-67. PubMed ID: 21887680
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Polymorphisms of homocysteine metabolism are associated with intracranial aneurysms.
    Semmler A, Linnebank M, Krex D, Götz A, Moskau S, Ziegler A, Simon M.
    Cerebrovasc Dis; 2008 Apr 01; 26(4):425-9. PubMed ID: 18799873
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients.
    Lambrecht L, Sleurs C, Labarque V, Dhooge C, Laenen A, Sinnaeve F, Renard M, Uyttebroeck A.
    Pharmacogenomics; 2017 Jun 01; 18(8):787-795. PubMed ID: 28592186
    [Abstract] [Full Text] [Related]

  • 20. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
    Crews KR, Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC.
    Cancer; 2004 Apr 15; 100(8):1724-33. PubMed ID: 15073863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.